The impact of endoscopic closure treatment on outcomes in patients with esophageal cancer-associated fistula: A retrospective analysis.

IF 3 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Digestion Pub Date : 2025-07-21 DOI:10.1159/000547231
Qijie Dai, Xian Zhao, Weipeng Lu, Yitian Wang, Jiepeng Cen, Heqing Tao, Liang Peng
{"title":"The impact of endoscopic closure treatment on outcomes in patients with esophageal cancer-associated fistula: A retrospective analysis.","authors":"Qijie Dai, Xian Zhao, Weipeng Lu, Yitian Wang, Jiepeng Cen, Heqing Tao, Liang Peng","doi":"10.1159/000547231","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Esophageal cancer-associated fistula is strongly linked to elevated mortality. This study aims to investigate the impact of endoscopic closure on outcomes in patients with esophageal cancer-related fistula.</p><p><strong>Methods: </strong>We retrospectively analyzed the clinical data of patients with esophageal cancer-related fistula. These patients were categorized into endoscopic closure group and conservative treatment group. The Clinical Pulmonary Infection Score (CPIS) gap, duration of hospitalization, ICU admission rates, in-hospital mortality rates, and hospitalization costs were compared between endoscopic group and conservative group. Additionally, factors associated with post-fistula survival and healing were assessed.</p><p><strong>Results: </strong>Univariate and multivariate COX regression analyses revealed that endoscopic closure could significantly improve short-term pulmonary infections based on CPIS gap (3 versus 2; P=0.004) but did not influence survival or fistula healing outcomes, and the hospitalization costs were elevated ($6653 versus $3350; P=0.005). Subgroup analysis focusing on esophagotracheal fistulas was also consistent with these results. Protective factors associated with improved survival prognosis included higher albumin levels (HR=0.928, 95%CI: 0.875-0.984, P=0.012), absence of bloodstream infections (positive blood culture (HR=23.055, 95%CI: 5.193-102.357, P<0.001)), non-T4 stage (T4 stage (HR=1.792, 95%CI: 1.052-3.052, P=0.032)) and no distant metastasis (distant metastasis (HR=2.122, 95%CI: 1.127-3.996, P=0.020)). Cervical esophageal fistula (upper (HR=0.154, 95% CI: 0.041-0.570, P=0.005); middle (HR=0.128, 95% CI: 0.027-0.609, P=0.010); lower (HR=0.218, 95% CI: 0.052-0.902, P=0.036)) was significantly associated with improved fistula healing outcomes, while a history of radiotherapy (HR=0.265, 95% CI: 0.089-0.788, P=0.017) was a risk factor for esophageal fistula healing.</p><p><strong>Conclusion: </strong>Our study indicates that multiple factors are significantly associated with the prognosis of patients with esophageal fistula. Endoscopic closure treatment effectively manages short-term infections but it associates with higher hospitalization costs and doesn't significantly enhance long-term healing or survival prognosis.</p>","PeriodicalId":11315,"journal":{"name":"Digestion","volume":" ","pages":"1-17"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Digestion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000547231","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Esophageal cancer-associated fistula is strongly linked to elevated mortality. This study aims to investigate the impact of endoscopic closure on outcomes in patients with esophageal cancer-related fistula.

Methods: We retrospectively analyzed the clinical data of patients with esophageal cancer-related fistula. These patients were categorized into endoscopic closure group and conservative treatment group. The Clinical Pulmonary Infection Score (CPIS) gap, duration of hospitalization, ICU admission rates, in-hospital mortality rates, and hospitalization costs were compared between endoscopic group and conservative group. Additionally, factors associated with post-fistula survival and healing were assessed.

Results: Univariate and multivariate COX regression analyses revealed that endoscopic closure could significantly improve short-term pulmonary infections based on CPIS gap (3 versus 2; P=0.004) but did not influence survival or fistula healing outcomes, and the hospitalization costs were elevated ($6653 versus $3350; P=0.005). Subgroup analysis focusing on esophagotracheal fistulas was also consistent with these results. Protective factors associated with improved survival prognosis included higher albumin levels (HR=0.928, 95%CI: 0.875-0.984, P=0.012), absence of bloodstream infections (positive blood culture (HR=23.055, 95%CI: 5.193-102.357, P<0.001)), non-T4 stage (T4 stage (HR=1.792, 95%CI: 1.052-3.052, P=0.032)) and no distant metastasis (distant metastasis (HR=2.122, 95%CI: 1.127-3.996, P=0.020)). Cervical esophageal fistula (upper (HR=0.154, 95% CI: 0.041-0.570, P=0.005); middle (HR=0.128, 95% CI: 0.027-0.609, P=0.010); lower (HR=0.218, 95% CI: 0.052-0.902, P=0.036)) was significantly associated with improved fistula healing outcomes, while a history of radiotherapy (HR=0.265, 95% CI: 0.089-0.788, P=0.017) was a risk factor for esophageal fistula healing.

Conclusion: Our study indicates that multiple factors are significantly associated with the prognosis of patients with esophageal fistula. Endoscopic closure treatment effectively manages short-term infections but it associates with higher hospitalization costs and doesn't significantly enhance long-term healing or survival prognosis.

内镜封闭治疗对食管癌相关瘘患者预后的影响:回顾性分析。
食管癌相关瘘与死亡率升高密切相关。本研究旨在探讨内镜关闭对食管癌相关瘘患者预后的影响。方法:回顾性分析食管癌相关性瘘患者的临床资料。将患者分为内镜封闭组和保守治疗组。比较内镜组与保守组的临床肺部感染评分(CPIS)差距、住院时间、ICU入院率、住院死亡率和住院费用。此外,还评估了瘘后生存和愈合的相关因素。结果:单因素和多因素COX回归分析显示,内镜关闭可显著改善基于CPIS间隙的短期肺部感染(3 vs 2;P=0.004),但不影响生存或瘘管愈合结果,住院费用升高(6653美元对3350美元;P = 0.005)。关注食管气管瘘的亚组分析也与这些结果一致。提高白蛋白水平(HR=0.928, 95%CI: 0.875 ~ 0.984, P=0.012)、无血流感染(血培养阳性HR=23.055, 95%CI: 5.193 ~ 102.357, P)是改善生存预后的保护因素。结论:本研究提示多种因素与食管瘘患者预后有显著相关性。内镜封闭治疗能有效控制短期感染,但住院费用较高,且不能显著提高长期愈合或生存预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Digestion
Digestion 医学-胃肠肝病学
CiteScore
7.90
自引率
0.00%
发文量
39
审稿时长
6-12 weeks
期刊介绍: ''Digestion'' concentrates on clinical research reports: in addition to editorials and reviews, the journal features sections on Stomach/Esophagus, Bowel, Neuro-Gastroenterology, Liver/Bile, Pancreas, Metabolism/Nutrition and Gastrointestinal Oncology. Papers cover physiology in humans, metabolic studies and clinical work on the etiology, diagnosis, and therapy of human diseases. It is thus especially cut out for gastroenterologists employed in hospitals and outpatient units. Moreover, the journal''s coverage of studies on the metabolism and effects of therapeutic drugs carries considerable value for clinicians and investigators beyond the immediate field of gastroenterology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信